Ciência Rural (Jul 2020)

Control of Conyza spp. with sequential application of glufosinate in soybean pre-sowing

  • Alfredo Junior Paiola Albrecht,
  • Leandro Paiola Albrecht,
  • André Felipe Moreira Silva,
  • Romulo Augusto Ramos,
  • Natália Buttini Corrêa,
  • Matheus Greguer de Carvalho,
  • Juliano Bortoluzzi Lorenzetti,
  • Maikon Tiago Yamada Danilussi

DOI
https://doi.org/10.1590/0103-8478cr20190868
Journal volume & issue
Vol. 50, no. 9

Abstract

Read online Read online

ABSTRACT: Conyza spp. is among the main weeds reported worldwide. Due to its aggressiveness, such as high seed production and dispersion, and the growing reports of biotypes resistant to glyphosate, paraquat, and other herbicides, different control practices are required. Thus, this study aimed to evaluate the efficacy of herbicides with sequential application of glufosinate in soybean pre-sowing for control of Conyza spp. with indicative of resistant to paraquat. The study was carried out in the field, at Assis Chateaubriand and Palotina, state of Paraná, Brazil, in the 2018/19 season. The experiments were conducted in a randomized block design with four replications. The treatments consisted in application of glyphosate, 2,4-D, saflufenacil, glufosinate, saflufenacil/imazethapyr, diclosulam, paraquat/diuron, paraquat and imazethapyr/flumioxazin, at different combinations, in soybean pre-sowing. Control of Conyza spp., crop injury to soybean plants and variables related to agronomic performance (plant height and yield) were evaluated. All treatments were selective for soybean, which showed stronger crop injury in the presence of diclosulam herbicide, but this did not compromise soybean agronomic performance. In general, control levels were high for the treatments used. Except for paraquat treatments, in the area with the highest frequency of Conyza spp. with indicative of resistant to paraquat, and imazethapyr/flumioxazin treatment in both areas. These control results emphasized the importance of glufosinate in this management system and showed promising results for saflufenacil/imazethapyr.

Keywords